These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27683954)

  • 21. Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity.
    Verdaguer J; Amrani A; Anderson B; Schmidt D; Santamaria P
    J Immunol; 1999 Apr; 162(8):4614-26. PubMed ID: 10202001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes.
    Ramanathan S; Dubois S; Chen XL; Leblanc C; Ohashi PS; Ilangumaran S
    J Immunol; 2011 May; 186(9):5131-41. PubMed ID: 21430227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Islet-specific expression of CXCL10 causes spontaneous islet infiltration and accelerates diabetes development.
    Rhode A; Pauza ME; Barral AM; Rodrigo E; Oldstone MB; von Herrath MG; Christen U
    J Immunol; 2005 Sep; 175(6):3516-24. PubMed ID: 16148094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
    J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
    Lejon K; Fathman CG
    J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8+ CD122+ PD-1- effector cells promote the development of diabetes in NOD mice.
    Arndt B; Witkowski L; Ellwart J; Seissler J
    J Leukoc Biol; 2015 Jan; 97(1):111-20. PubMed ID: 25387835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
    Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
    J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An inducible transgenic mouse breast cancer model for the analysis of tumor antigen specific CD8+ T-cell responses.
    Bruns M; Wanger J; Utermöhlen O; Deppert W
    Oncotarget; 2015 Nov; 6(36):38487-503. PubMed ID: 26513294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage.
    Bercovici N; Heurtier A; Vizler C; Pardigon N; Cambouris C; Desreumaux P; Liblau R
    J Immunol; 2000 Jul; 165(1):202-10. PubMed ID: 10861053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tc17 CD8+ T cells potentiate Th1-mediated autoimmune diabetes in a mouse model.
    Saxena A; Desbois S; Carrié N; Lawand M; Mars LT; Liblau RS
    J Immunol; 2012 Sep; 189(6):3140-9. PubMed ID: 22904307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An altered self-peptide with superagonist activity blocks a CD8-mediated mouse model of type 1 diabetes.
    Hartemann-Heurtier A; Mars LT; Bercovici N; Desbois S; Cambouris C; Piaggio E; Zappulla J; Saoudi A; Liblau RS
    J Immunol; 2004 Jan; 172(2):915-22. PubMed ID: 14707063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Diabetogenic CD8+ T Cells: IMMUNE THERAPY WITH METABOLIC BLOCKADE.
    Garyu JW; Uduman M; Stewart A; Rui J; Deng S; Shenson J; Staron MM; Kaech SM; Kleinstein SH; Herold KC
    J Biol Chem; 2016 May; 291(21):11230-40. PubMed ID: 26994137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis of autoreactive CD8 lymphocytes as a potential mechanism for the abrogation of type 1 diabetes by islet-specific TNF-alpha expression at a time when the autoimmune process is already ongoing.
    Christen U; Von Herrath MG
    Ann N Y Acad Sci; 2002 Apr; 958():166-9. PubMed ID: 12021099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma.
    Lee MS; von Herrath M; Reiser H; Oldstone MB; Sarvetnick N
    J Clin Invest; 1995 Feb; 95(2):486-92. PubMed ID: 7860730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: lessons from transgenic mouse models.
    Piaggio E; Hartemann-Heurtier A; Cabarrocas J; Desbois S; Mars LT; Zappulla JP; Liblau RS
    J Autoimmun; 2004 Mar; 22(2):115-20. PubMed ID: 14987739
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of memory-like autoregulatory CD8+ T cells is CD4+ T cell dependent.
    Shameli A; Clemente-Casares X; Wang J; Santamaria P
    J Immunol; 2011 Sep; 187(6):2859-66. PubMed ID: 21824864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis.
    Christen U; Wolfe T; Möhrle U; Hughes AC; Rodrigo E; Green EA; Flavell RA; von Herrath MG
    J Immunol; 2001 Jun; 166(12):7023-32. PubMed ID: 11390446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis and treatment of virus-induced autoimmune diabetes: novel insights gained from the RIP-LCMV transgenic mouse model.
    von Herrath MG; Homann D; Gairin JE; Oldstone MB
    Biochem Soc Trans; 1997 May; 25(2):630-5. PubMed ID: 9191170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.